Rothschild Investment LLC’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.4K Sell
457
-9
-2% -$1.11K ﹤0.01% 1196
2026
Q1
$54.9K Buy
466
+10
+2% +$1.4K ﹤0.01% 1084
2025
Q4
$74.7K Buy
456
+3
+0.7% +$470 ﹤0.01% 904
2025
Q3
$60.6K Buy
453
+3
+0.7% +$364 ﹤0.01% 943
2025
Q2
$56K Sell
450
-3
-0.7% -$382 ﹤0.01% 757
2025
Q1
$57.6K Buy
453
+1
+0.2% +$154 ﹤0.01% 730
2024
Q4
$65.1K Buy
452
+1
+0.2% +$143 ﹤0.01% 731
2024
Q3
$67.1K Buy
451
+1
+0.2% +$143 ﹤0.01% 728
2024
Q2
$56.7K Hold
450
﹤0.01% 728
2024
Q1
$82.8K Hold
450
0.01% 632
2023
Q4
$80.9K Buy
+450
New +$70K 0.01% 579

Other funds holding RGEN

Rothschild Investment LLC's RGEN Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Repligen (RGEN) stake by 1.9% in Q2 2026, selling an estimated $1.11K and leaving 457 shares worth $62.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1196.

Rothschild Investment LLC first reported a position in RGEN in Q4 2023 and has held it in 11 quarters since. The position peaked at $82.8K in Q1 2024. 213 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Rothschild Investment LLC held 457 shares of Repligen worth $62.4K as of Q2 2026.
  • Rothschild Investment LLC sold 9 Repligen shares in Q2 2026, an estimated $1.11K.
  • Repligen made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1196 holding.
  • Rothschild Investment LLC first reported a position in Repligen in Q4 2023 and has held it in 11 quarters since.
  • Rothschild Investment LLC's Repligen position peaked at $82.8K in Q1 2024.
  • 213 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.